Literature DB >> 27085736

Targeting Iron Homeostasis in Acute Kidney Injury.

Vyvyca J Walker1, Anupam Agarwal2.   

Abstract

Iron is an essential metal involved in several major cellular processes required to maintain life. Because of iron's ability to cause oxidative damage, its transport, metabolism, and storage is strictly controlled in the body, especially in the small intestine, liver, and kidney. Iron plays a major role in acute kidney injury and has been a target for therapeutic intervention. However, the therapies that have been effective in animal models of acute kidney injury have not been successful in human beings. Targeting iron trafficking via ferritin, ferroportin, or hepcidin may offer new insights. This review focuses on the biology of iron, particularly in the kidney, and its implications in acute kidney injury.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Iron; ferritin; ferroportin; hepcidin; injury; kidney

Mesh:

Substances:

Year:  2016        PMID: 27085736      PMCID: PMC5439503          DOI: 10.1016/j.semnephrol.2016.01.003

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  99 in total

1.  Hepcidin Mitigates Renal Ischemia-Reperfusion Injury by Modulating Systemic Iron Homeostasis.

Authors:  Yogesh Scindia; Paromita Dey; Abhinav Thirunagari; Huang Liping; Diane L Rosin; Matteo Floris; Mark D Okusa; Sundararaman Swaminathan
Journal:  J Am Soc Nephrol       Date:  2015-03-18       Impact factor: 10.121

2.  Renal preservation after warm ischemia using oxygen free radical scavengers to prevent reperfusion injury.

Authors:  P Baron; O Gomez-Marin; C Casas; J Heil; N Will; R Condie; B Burke; J S Najarian; D E Sutherland
Journal:  J Surg Res       Date:  1991-07       Impact factor: 2.192

3.  The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.

Authors:  Adriana Donovan; Christine A Lima; Jack L Pinkus; Geraldine S Pinkus; Leonard I Zon; Sylvie Robine; Nancy C Andrews
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

4.  Superoxide-mediated release of iron from ferritin by some flavoenzymes.

Authors:  Y Bando; K Aki
Journal:  Biochem Biophys Res Commun       Date:  1990-04-30       Impact factor: 3.575

5.  Hepatic and extrahepatic expression of the new iron regulatory protein hemojuvelin.

Authors:  Alejandra Rodriguez Martinez; Onni Niemelä; Seppo Parkkila
Journal:  Haematologica       Date:  2004-12       Impact factor: 9.941

6.  Glomerular protein sieving and implications for renal failure in Fanconi syndrome.

Authors:  A G Norden; M Lapsley; P J Lee; C D Pusey; S J Scheinman; F W Tam; R V Thakker; R J Unwin; O Wrong
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

7.  Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury.

Authors:  Jay L Koyner; Vishal S Vaidya; Michael R Bennett; Qing Ma; Elaine Worcester; Shahab A Akhter; Jai Raman; Valluvan Jeevanandam; Micheal F O'Connor; Prasad Devarajan; Joseph V Bonventre; Patrick T Murray
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-26       Impact factor: 8.237

Review 8.  Treatment of acute renal failure.

Authors:  R A Star
Journal:  Kidney Int       Date:  1998-12       Impact factor: 10.612

9.  Receptor-modulated iron release from transferrin: differential effects on N- and C-terminal sites.

Authors:  P K Bali; P Aisen
Journal:  Biochemistry       Date:  1991-10-15       Impact factor: 3.162

10.  Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.

Authors:  Kianoush Kashani; Ali Al-Khafaji; Thomas Ardiles; Antonio Artigas; Sean M Bagshaw; Max Bell; Azra Bihorac; Robert Birkhahn; Cynthia M Cely; Lakhmir S Chawla; Danielle L Davison; Thorsten Feldkamp; Lui G Forni; Michelle Ng Gong; Kyle J Gunnerson; Michael Haase; James Hackett; Patrick M Honore; Eric A J Hoste; Olivier Joannes-Boyau; Michael Joannidis; Patrick Kim; Jay L Koyner; Daniel T Laskowitz; Matthew E Lissauer; Gernot Marx; Peter A McCullough; Scott Mullaney; Marlies Ostermann; Thomas Rimmelé; Nathan I Shapiro; Andrew D Shaw; Jing Shi; Amy M Sprague; Jean-Louis Vincent; Christophe Vinsonneau; Ludwig Wagner; Michael G Walker; R Gentry Wilkerson; Kai Zacharowski; John A Kellum
Journal:  Crit Care       Date:  2013-02-06       Impact factor: 9.097

View more
  13 in total

1.  Acute and Chronic Iron Overloading Differentially Modulates the Expression of Cellular Iron-homeostatic Molecules in Normal Rat Kidney.

Authors:  Bassem Refaat; Abdelghany Hassan Abdelghany; Mohammad A BaSalamah; Mohamed El-Boshy; Jawwad Ahmad; Shakir Idris
Journal:  J Histochem Cytochem       Date:  2018-06-06       Impact factor: 2.479

Review 2.  Ferritins in Kidney Disease.

Authors:  Kayla McCullough; Subhashini Bolisetty
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

Review 3.  Acute kidney injury: emerging pharmacotherapies in current clinical trials.

Authors:  Stefanie Woolridge Benoit; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2017-06-10       Impact factor: 3.714

4.  Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition.

Authors:  Yuntao Bai; Ji Young Kim; Bijay Bisunke; Laura A Jayne; Josie A Silvaroli; Michael S Balzer; Megha Gandhi; Kevin M Huang; Veronika Sander; Jason Prosek; Rachel E Cianciolo; Sharyn D Baker; Alex Sparreboom; Kenar D Jhaveri; Katalin Susztak; Amandeep Bajwa; Navjot Singh Pabla
Journal:  Kidney Int       Date:  2021-09-15       Impact factor: 18.998

5.  Ferrotoxicity and its amelioration by endogenous vitamin D in experimental acute kidney injury.

Authors:  Chandrashekar Annamalai; Rajesh N Ganesh; Pragasam Viswanathan
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-02

Review 6.  Heme Oxygenase 1 as a Therapeutic Target in Acute Kidney Injury.

Authors:  Subhashini Bolisetty; Abolfazl Zarjou; Anupam Agarwal
Journal:  Am J Kidney Dis       Date:  2017-01-27       Impact factor: 8.860

Review 7.  Advances in pediatric acute kidney injury.

Authors:  Rupesh Raina; Ronith Chakraborty; Abhishek Tibrewal; Sidharth K Sethi; Timothy Bunchman
Journal:  Pediatr Res       Date:  2021-03-17       Impact factor: 3.756

8.  Lipopolysaccharide Pretreatment Prevents Medullary Vascular Congestion following Renal Ischemia by Limiting Early Reperfusion of the Medullary Circulation.

Authors:  Sarah R McLarnon; Katie Wilson; Bansari Patel; Jingping Sun; Christina L Sartain; Christopher D Mejias; Jacqueline B Musall; Jennifer C Sullivan; Qingqing Wei; Jian-Kang Chen; Kelly A Hyndman; Brendan Marshall; Haichun Yang; Agnes B Fogo; Paul M O'Connor
Journal:  J Am Soc Nephrol       Date:  2022-02-03       Impact factor: 14.978

Review 9.  Programmed Necrosis and Disease:We interrupt your regular programming to bring you necroinflammation.

Authors:  Eui Ho Kim; Sing-Wai Wong; Jennifer Martinez
Journal:  Cell Death Differ       Date:  2018-10-22       Impact factor: 15.828

10.  Exposure to Iron Oxide Nanoparticles Coated with Phospholipid-Based Polymeric Micelles Induces Renal Transitory Biochemical and Histopathological Changes in Mice.

Authors:  Mihaela Balas; Ioana Mihaela Popescu Din; Anca Hermenean; Ludmila Otilia Cinteza; Anca Dinischiotu
Journal:  Materials (Basel)       Date:  2021-05-17       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.